Patents by Inventor Emil Velthuisen

Emil Velthuisen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
    Publication number: 20050119246
    Abstract: Disclosed are pyrazolyl derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formula (I) or (II): wherein the variables R, R1, R2, R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.
    Type: Application
    Filed: December 28, 2002
    Publication date: June 2, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Gaetan Ladouceur, Emil Velthuisen, Soongyu Choi, Yamin Wang, Jeremy Baryza, Philip Coish, William Bullock, Roger Smith, Jinshan Chen
  • 4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
    Publication number: 20050119489
    Abstract: Disclosed are 4-sulfide/sulfoxide/sulfonyl-1H-pyrazolyl derivative compounds of formulas (I) or (II): wherein the variables n, R, R1, R2, R3, R3?, R4, R4?, R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.
    Type: Application
    Filed: December 28, 2002
    Publication date: June 2, 2005
    Inventors: Gaetan Ladouceur, Emil Velthuisen, Soongyu Choi, Zhonghua Zhang, Yamin Wang, Jeremy Baryza, Philip Coish, Roger Smith, Jinshan Chen